Mediation of laser trabeculoplasty-induced matrix metalloproteinase expression by IL-1β and TNFα

Investigative Ophthalmology and Visual Science

Volumn 41, Issue 2, 2000, Pages 422-430

  Bradley, John M B ^a   Anderssohn, Ann Marie ^a   Colvis, Christine M ^a   Parshley, Dorothy E ^a   Zhu, XiangHong ^a   Ruddat, Michael S ^a   Samples, John R ^a   Acott, Ted S ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; MATRIX METALLOPROTEINASE; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN ANTIBODY COMPLEX; ARTICLE; EXTRACELLULAR MATRIX; GENE EXPRESSION; GLAUCOMA; HUMAN; HUMAN TISSUE; HYPOTHESIS; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRABECULAR MESHWORK; TRABECULOPLASTY;

ANIMALS; ANTERIOR EYE SEGMENT; ANTIBODIES, BLOCKING; BLOTTING, WESTERN; CULTURE MEDIA; CULTURE MEDIA, CONDITIONED; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; LASER SURGERY; MATRIX METALLOPROTEINASE 3; MICROSCOPY, CONFOCAL; ORGAN CULTURE TECHNIQUES; RNA, MESSENGER; SIALOGLYCOPROTEINS; SWINE; TRABECULECTOMY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033973409     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Shields MB. Textbook of Glaucoma. 4th ed. Baltimore: Williams & Wilkins; 1998.
2. Quigley HA. Open-angle glaucoma. New Engl J Med. 1993:328: 1097-1106.
3. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol. 1996;80:389-393.
4. Quigley HA, Vitale S. Models of open-angle glaucoma prevalence and incidence in the United States. Invest Ophthalmol Vis Sci. 1997;38:83-91.
5. Bito LZ. Glaucoma: a physiologic perspective with Darwinian overtones. J Glaucoma. 1992;1:195-205.
6. Kolker AE, Hetherington J Jr, eds. Becker-Shaffer's Diagnosis and Therapy of the Glaucomas. 5th ed. St. Louis: Mosby-Year Book, Inc: 1983.
7. Van Buskirk EM, Cioffi GA. Glaucomatous optic neuropathy. Am J Ophthalmol. 1992;113:447-452.
8. Weinreb RN, Tsai CS. Laser trabeculoplasty. In: Ritch R, Shields MB, Krupin T, eds, The Glaucomas. Vol. 3, 2nd ed. St Louis: Moshy; 1996:1575-1590.
9. Ritch R, Solomon IS. Laser treatment of glaucoma. In: L'Esperance FAJ. Ed. Ophthalmic Lasers. Vol. II. 3rd ed. St. Louis: CV Mosby; 1989:650-748.
10. Schwartz LW, Spaeth CL, Traverso C, Greenidge KC. Variation in techniques on the results of argon laser trabeculoplasty. Ophthalmology, 1983:90:781-784.
11. Weinreb RN, Ruderman J, Juster R, Wilinsky JT. Influence of the number of laser burns administered on the early results of argon laser trabeculoplasty. Am J Ophthalmol. 1983;95:287-292.
12. Weinreb RN, Ruderman J, Juster R, Zweig K. Immediate intraocular pressure response to argon laser trabeculoplasty. Am J Ophthalmol. 1983;95:279-286.
13. Wilinsky JT, Jampol LM. Laser therapy for open angle glaucoma. Ophthalmology, 1981;88:213-217.
14. Wise JB. Twelve-year control of primary open-angle glaucoma by argon laser trabeculoplasty. In: Mills KB, ed. Glaucoma. Oxford: Hergamon Press; 1989:138-141.
15. Wise JB. Long-term control of adult open angle glaucoma by argon laser treatment. Ophthalmoogyl, 1981;88:197-202.
16. Brubaker RF, Liesegang TJ. Effect of trabecular photocoagulation on the aqueous humor dynamics of the human eye. Am J Ophthalmol. 1983;96:139-147.
17. Van Buskirk EM. Pathophysiology of laser trabeculoplasty. Surv Ophthalmol. 1989;33:264-272.
18. Drance SM, Douglas GR, Schulzer M, Wijsman K. The effects of laser trabeculoplasty on intraocular pressure and some visual functions. In: Krieglstein GK, ed. Glaucoma Update III. Berlin: Springer-Verlag; 1987:207-214.
19. Grinch NP, Van Buskirk EM, Samples JR. Three-year efficacy of argon laser trabeculoplasty. Ophthalmology, 1987;94:858-861.
20. Brown SVL, Thomas JV, Simmons RJ. Laser trabeculoplasty retreatment. Am J Ophthalmol. 1985;99:8-10.
21. Grayson DK, Camras CB, Podos SM, Lustgarten JS. Long-term reduction of intraocular pressure after repeat argon laser trabeculoplasty. Am J Ophthalmol. 1988;106:312-321.
22. Messner D, Siegel LI, Kass MA, Kolker AE, Gordon M. Repeat argon laser trabeculoplasty. Am J Ophthalmol. 1987;103:113-115.
23. Bylsma SS, Samples JR, Acott TS, Van Buskirk EM. Trabecular cell division after argon laser trabeculoplasty. Arch Ophthalmol. 1988; 106:544-547.
24. Bylsma SS, Samples JR, Acott TS, Pirouzkar B, Van Buskirk EM. DNA replication in the cat trabecular meshwork after laser trabeculoplasty in vivo. J Glaucoma. 1994;3:36-43.
25. 3H-thymidine labeling; an autoradiographic study in cats. Curr Eye Res. 1992;11:297-306.
26. Dueker DK, Norberg M, Johnson DH, Tschemper RC, Feeney-Burns L. Stimulation of cell division by argon and Nd-YAG laser trabeculoplasty in cynomolgus monkeys. Invest Ophthalmol Vis Sci. 1990;31:115-124.
27. Acott TS, Samples JR, Bradley JMB, Bacon DR, Bylsma SS, Van Buskirk EM. Trabecular repopulation by anterior trabecular meshwork cells after laser trabeculoplasty. Am J Ophthalmol. 1989;107: 1-6.
28. Rodrigues MM, Spaeth GL, Donohoo P. Electron microscopy of argon laser therapy in phakic open-angle glaucoma. Ophthalmology. 1982;89:198-210.
29. van der Zypen E. The effects of lasers on outflow structures. In: Krieglstein GK, ed. Glaucoma Update III. Berlin: Springer-Verlag; 1987:169-176.
30. van der Zypen E, Fankhauser F. Ultrastructural changes of the trabecular meshwork of the monkey (Macaca speciosa) following irradiation with argon laser light. Graefes Arch Clin Exp Ophthalmol. 1984;221:249-261.
31. Van Buskirk EM, Pond V, Rosenquist RC, Acott TS. Argon laser trabeculoplasty - studies of mechanism of action. Ophthalmology. 1984;91:1005-1010.
32. Weber PA, Davidorf FH, McDonald C. Scanning electron microscopy of argon laser trabeculoplasty. Ophthalmic Forum. 1983;1: 26-29.
33. Melamed S, Pei U, Epstein DL. Short-term effect of argon laser trabeculoplasty in monkeys. Arch Ophthalmol. 1985;103:1546-1552.
34. Melamed S, Pei J, Epstein DL. Delayed response to argon laser trabeculoplasty in monkeys: morphological and morphometric analysis. Arch Ophthalmol. 1986;104:1078-1083.
35. Melamed S, Epstein DL. The trabecular response to argon and Nd-YAG laser energy. In: Krieglstein GK, ed. Glaucoma Update III. Berlin: Springer-Verlag; 1987:177-184.
36. Melamed S, Epstein DL. Alterations of aqueous humour outflow following argon laser trabeculoplasty in monkeys. Br J Ophthalmol. 1987;71:776-781.
37. Pollack IP, Robin AL, Streisfeld DL, et al. Neodymium-YAG laser. Histopathology of effects upon monkey trabecular meshwork and role in the treatment of open-angle glaucoma In: Krieglstein GK, ed. Glaucoma Update III. Berlin: Springer-Verlag; 1987:185-193.
38. Mchugh D, Marshall J, Ffytche TJ, Hamilton PAM, Raven A. Ultrastructural changes of human trabecular meshwork after photocoagulation with a diode laser. Invest Ophthalmol Vis Sci. 1992;33: 2664-2671.
39. Parshley DE, Bradley JMB, Samples JR, Van Buskirk EM, Acott TS. Early changes in matrix metalloproteinases and inhibitors after in vivo laser treatment to the trabecular meshwork. Cur Eye Res. 1995;14:537-544.
40. Parshley DE, Bradley JMB, Fisk A, et al. Laser trabeculoplasty induces stromelysin expression by trabecular juxtacanalicular cells. Invest Ophthalmol Vis Sci. 1996;37:795-804.
41. Murphy G, Willenbrock F, Crabbe T, et al. Regulation of matrix metalloproteinase activity [Review]. Ann NY Acad Sci. 1994;732: 31-41.
42. Woessner JFJ. The family of matrix metalloproteinases [Review]. Ann NY Acad Sci. 1994;732:11-21.
43. Birkedal-Hansen H, Moore WG, Bodden MK, et al. Matrix metalloproteinases: a review [Review]. Crit Rev Oral Biol Med. 1993;4:197-250.
44. Parsons SL, Watson SA, Brown PD, Collins HM, Steele RJ. Matrix metalloproteinases. Br J Surg. 1997;84:160-166.
45. Shapiro SD. Matrix metalloproteinase degradation of extracellular matrix: biological consequences. Curr Opin Cell Biol. 1998;10: 602-608.
46. Werb Z, Chin JR. Extracellular matrix remodeling during morphogenesis. Ann NY Acad Sci. 1998;857:110-118.
47. Acott TS. Biochemistry of aqueous humor outflow. In: Kaufman PL, Mittag TW, eds. Textbook of Ophthalmology. Vol. 7. London: Mosby; 1994:1.47-41.78.
48. Acott TS, Wirtz MK. Biochemistry of aqueous outflow. In: Ritch R, Shields MB, Krupin T, eds. The Glaucomas. Vol. I, 2nd ed. St Louis: Mosby; 1996:281-305.
49. Alexander JP, Samples JR, Van Buskirk EM, Acott TS. Expression of matrix metalloproteinases and inhibitor by human trabecular meshwork. Invest Ophthalmol Vis Sci. 1991;32:172-180.
50. Bradley JMB, Vranka JA, Colvis CM, et al. Effects of matrix metalloproteinase activity on outflow in perfused human organ culture. Invest Ophthalmol Vis Sci. 1998;39:2649-2658.
51. Alexander JP, Samples JR, Acott TS. Growth factor and cytokine modulation of trabecular meshwork matrix metalloproteinase and TIMP expression. Curr Eye Res. 1998;17:276-285.
52. Samples JR, Alexander JP, Acott TS. Regulation of the levels of human trabecular matrix metalloproteinases and inhibitor by interleukin-1 and dexamethasone. Invest Ophthalmol Vis Sci. 1993; 34:3386-3395.
53. Acott TS, Kingsley PD, Samples JR, Van Buskirk EM. Human trabecular meshwork organ culture: morphology and glycosaminoglycan synthesis. Invest Ophthalmol Vis Sci. 1988;29:90-100.
54. Acott TS, Westcott M, Passo MS, Van Buskirk EM. Trabecular meshwork glycosaminoglycans in human and cynomolgus monkey eye. Invest Ophthalmol Vis Sci. 1985;26:1320-1329.
55. Vranka JA, Johnson E, Zhu X, et al. Discrete expression and distribution pattern of TIMP-3 in the human retina and choroid. Cur Eye Res. 1997;16:102-110.
56. Wirtz MK, XU H, Rust K, Alexander JP, Acott TS. Insulin-like growth factor binding protein-5 expression by human trabecular meshwork. Invest Ophthalmol Vis Sci. 1998;39:45-53.
57. Alexander JP, Bradley JMB, Gabourel JD, Acott TS. Expression of matrix metalloproteinases and inhibitor by human retinal pigment epithelium. Invest Ophthalmol Vis Sci. 1990;31:2520-2528.
58. Chomczynski P, Sacchi N. Single-step method for RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
59. Shiuey Y, Yun AJ, Hoover K, Underwood JL, Murphy GC, Alvarado JA. The role of heat in the cellular response to laser injury [ARVO Abstract]. Invest Ophthalmol Vis Sci. 1993;34(4):S1385. Abstract nr 3365.
60. Dinarello CA. Biologic basis for interleukln-1 in disease. Blood. 1996;87:2095-2147.
61. Dinarello CA. Interleukin-1. Cytokine Growth Factor Rev. 1997;8: 253-265.
62. Dinarello CA. Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. Int Rev Immunol. 1998;16:457-499.
63. Saklatvala J, Davis W, Guesdon F. Interleukin 1 (IL1) and tumor necrosis factor (TNF) signal transduction. Philos Trans R Soc London B Biol Sci. 1996;351:151-157.
64. Bankers-Fulbright JL, Kalli KR, McKean DJ. Interleukin-1 signal transduction. Life Sci. 1996;59:61-83.
65. Bacon D, Bylsma SS, Gradin D, Acott TS, Samples JR, Van Buskirk EM. Effect of wavelength on trabecular cell division after laser trabeculoplasty [ARVO Abstract]. Invest Ophthalmol Vis Sci. 1990; 31(4):S340. Abstract nr 1673.